Related Articles
Novel FGFR inhibitor ponatinib suppresses the growth of non-small cell lung cancer cells overexpressing FGFR1
FGFR inhibitors: Effects on cancer cells, tumor microenvironment and whole-body homeostasis (Review)
Targeting VEGFR and FGFR in head and neck squamous cell carcinoma in vitro
FGFR inhibitor AZD4547 can enhance sensitivity of esophageal squamous cell carcinoma cells with epithelial‑mesenchymal transition to gefitinib
8p11 Myeloproliferative syndrome with t(8;22)(p11;q11): A case report